Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$278M Buy
4,625,000
+1,355,000
+41% +$63.2M 2.27% 6
2026
Q1
$118M Buy
3,270,000
+270,000
+9% +$11.3M 1.23% 15
2025
Q4
$141M Sell
3,000,000
-74,801
-2% -$3.16M 1.46% 17
2025
Q3
$99.9M Hold
3,074,801
1.18% 20
2025
Q2
$127M Buy
3,074,801
+476,363
+18% +$18.4M 1.79% 8
2025
Q1
$108M Buy
2,598,438
+884,423
+52% +$46M 2.07% 8
2024
Q4
$100M Buy
1,714,015
+1,420,569
+484% +$84M 1.34% 11
2024
Q3
$20.3M Buy
+293,446
New +$19M 0.34% 79

Other funds holding BRKR

Sculptor Capital's BRKR Position: Q2 2026 in Review

Sculptor Capital increased its Bruker (BRKR) stake by 41% in Q2 2026, buying an estimated $63.2M and bringing the position to 4,625,000 shares worth $278M. The position accounts for 2.27% of the portfolio, ranked #6.

Sculptor Capital first reported a position in BRKR in Q3 2024 and has held it in 8 quarters since. 415 funds tracked by Wall St. Rank hold BRKR as of Q2 2026.

  • Sculptor Capital held 4,625,000 shares of Bruker worth $278M as of Q2 2026.
  • Sculptor Capital bought 1,355,000 Bruker shares in Q2 2026, an estimated $63.2M.
  • Bruker made up 2.27% of Sculptor Capital's portfolio in Q2 2026, its #6 holding.
  • Sculptor Capital first reported a position in Bruker in Q3 2024 and has held it in 8 quarters since.
  • 415 funds tracked by Wall St. Rank held Bruker as of Q2 2026.

Based on Sculptor Capital's 13F filing for Q2 2026, filed 14 Aug 2026.